echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > 3.5 billion dollars!

    3.5 billion dollars!

    • Last Update: 2021-07-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On July 27, PeptiDream and Takeda announced the expansion of Shuangfa's exclusive cooperation to develop peptide-conjugated drugs (PDCs) around the central nervous system (CNS) target


    PeptiDream and Takeda initially reached an exclusive cooperation license agreement in December 2020.


    A major challenge in developing new drugs for neurodegenerative diseases is the ability to deliver drug molecules across the blood-brain barrier to the brain


    PeptiDream's proprietary peptide discovery platform system (Peptide Discovery Platform System, PDPS) is an advanced and highly versatile discovery platform that can efficiently produce highly diversified (trillion) non-standard peptide libraries for identification of effectiveness and selection Sexual hit candidates can then be developed into therapies based on peptides, small molecules or peptide-drug conjugate drugs


    Note: The original text has been deleted

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.